Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam

Gregory L. Krauss, A. Bergin, R. E. Kramer, Y. W. Cho, S. G. Reich

Research output: Contribution to journalArticlepeer-review

90 Scopus citations


Posthypoxic and postencephalitic myoclonus is often poorly controlled with current treatments. The authors successfully treated three patients with posthypoxic and postencephalitic myoclonus by using levetiracetam, a new antiepileptic drug. Levetiracetam appears to be a promising agent for treating action myoclonus caused by hypoxic and encephalitic brain injury - the degree of functional improvement may depend on the severity of associated motor dysfunction.

Original languageEnglish (US)
Pages (from-to)411-412
Number of pages2
Issue number3
StatePublished - Feb 13 2001

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam'. Together they form a unique fingerprint.

Cite this